Pursuant to Order of the Hyderabad Bench of the National Company Law Tribunal {NCLT Order), Glenmark Pharmaceuticals has informed that the operations of Karvy Computershare Private Limited (KCPL), the Registrar and Share Transfer Agent of the company have been transferred to Karvy Fintech with effect from 17th November, 2018. The company has further informed that pursuant to the NCLT Order, all the existing agreements to which KCPL is a party including the agreements entered into by the company shall be in full force and vest with Karvy Fintech.
The above information is a part of company’s filings submitted to BSE.
